The CEO talks growth challenges, the consequences of this year’s volatility and how the Great Wealth Transfer is reshaping the advisor space.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
And yet, last week, Tesla scored a couple key brownie points from Wall Street analysts. So why the optimism?
The hope for the S&P 500’s small-cap cousin after the Fed’s rate cut tells an important story about the broader economy.
Demand for copper, already one of the most commonly used metals in the world, has surged amid the AI computing boom.
iPhone sales surged to $44.5 billion in the quarter ending in June, besting analysts’ $40 billion expectations and rising 14% year-over-year.
Small, mountainous Switzerland — a country that ranks 61st in the world by total area — is one of the world’s biggest investors in the US.
The department store also seems cautiously optimistic for the holidays, raising its profit forecast for the year.
In the last decade, global government bonds with maturities over 10 years suffered a median loss of 2% in September, according Bloomberg.
Two key forces were to thank: consumers, who spent more than original estimates, and businesses, which did the same.
After the Peet’s acquisition, Keurig Dr Pepper says it will split into two companies: one focused on coffee and the other on soft drinks.
An index of sales prices rose at its fastest pace in three years as tariffs wound their way into the supply chain.
Wednesday’s earnings call also brought news that longtime target chief executive officer Brian Cornell is leaving his post.
Shares in rival used car retailers went into reverse gear following the announcement of Hertz’s Amazon partnership.
President Trump placed 25% tariffs on aluminum and steel imports in March via executive order, before hiking the rate to 50% on Tuesday.
For those keeping score at home, that’s in addition to the $500 billion in domestic investments Apple announced earlier this year.
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.